Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

5.09
Delayed Data
As of Mar 23
 +0.24 / +4.95%
Today’s Change
4.51
Today|||52-Week Range
11.19
-3.60%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close4.85
Today’s open4.87
Day’s range4.86 - 5.09
Volume7,999
Average volume (3 months)20,606
Market cap$77.2M
Dividend yield--
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)+18.67%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.88

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc+0.03+1.18%
AGRXAgile Therapeutics I...+0.27+10.04%
LPCNLipocine Inc-0.01-0.24%
ATNMActinium Pharmaceuti...+0.04+2.84%
Data as of 4:02pm ET, 03/23/2017

Financials

Last reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$0.00
Annual profit (last year)-$17.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc Steven Hanover
Vice President-Finance &
Accounting
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts


Search for Jobs